Chemotherapy effect on locally advanced non small cell lung carcinoma: A randomized study on 353 patients
β Scribed by R. Arriagada; T. Le Chevalier; E. Quoix; P. Ruffle; M. Tarayre; J.Y. Douillard; M. Martin
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 133 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. In a previous study the authors demonstrated, using immunohistochemical methods for epithelial antigens, that the regional lymph nodes of gastric adenocarcinoma contained individual tumor cells or small clusters of these cells (tumor cell microinvolvement [TCM]) in over 90% of cases
## Abstract ## BACKGROUND The authors compared the toxicity, response rate, and progression free survival of four chemotherapy regimens for patients with advanced (Stage IIIB and IV) nonsmall cell lung carcinoma. ## METHODS A total of 267 patients entered this randomized Phase II trial on one of
## Abstract ## BACKGROUND Preclinical and clinical evidence suggests that a fixed infusion rate of 10 mg/m^2^ per minute may be more effective than the standard 30βminute infusion of gemcitabine. To investigate the activity and toxicity of the cisplatin plus gemcitabine combination with gemcitabin
## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel